Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger

MT Newswires Live01-02

Hookipa Pharma (HOOK) and Poolbeg Pharma said Thursday that they have entered into non-binding discussions for an all-share acquisition by Hookipa of Poolbeg.

Under the terms of the potential combination, based on discussions so far, Poolbeg shareholders will receive 0.03 Hookipa shares for each share held, the companies said.

Poolbeg shareholders are expected to receive 55% of the equity in the combined firm, while Hookipa will hold the remainder, the company said.

Hookipa plans to raise up to $30 million through a 100% primary private placement immediately following the merger, the companies said.

The fundraising is expected to be completed around the same time as the potential merger in early Q2, the companies added.

Hookipa will be the sole stock market-listed entity for the new company and Poolbeg will become a private unit as part of the proposed deal, the companies said.

Shares of Hookipa were up 8% in recent Thursday premarket activity.

Price: 2.17, Change: +0.16, Percent Change: +7.96

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment